Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Comment by dimar66on Mar 31, 2011 1:21pm
371 Views
Post# 18367962

RE: RE: Gross Margin

RE: RE: Gross MarginThe removal of Kay would save us, if it is not too late, Orbimed has shown good initiative in cutting costs which should have been done long ago.  Holler and Co have been asleep at the wheel.  Another point about margins we must not forget is that the Ramp reader only makes a small profit or may be sold at a discount; while the test cartridges are much more profitable, so as the demand for test cartridges increases so will margins
Bullboard Posts